Cytec Industries — Q3 2012 Earnings Presentation
16 slides from Cytec Industries's earnings presentation, Oct 19, 2012
Slide 1: Third Quarter 2012 Earnings Review
Third Quarter 2012 Earnings Review Shane Fleming – Chairman, President and CEO Dave Drillock – Vice President and CFO October 19, 2012
Slide 2: Forward Looking Statement
Forward Looking Statement During the course of this meeting we may make forward-looking statements. All statements that address expectations or projections about the future are forward-looking statements. Some of these statements include words such as “expects”, “anticipates,” “plans,” “intends,” “p
Slide 3: Results Overview
Results Overview Q3 As Adjusted EPS 3rd Quarter 2012 2012 vs. 2011 $3.50 Continuing Operations* $3.00 $2.30 $2.50 Sales of $455M $2.00 YTD $1.50 $1.11 Earnings of $42.8M or 3rd Qtr $1.00 $0.91 per diluted share $0.50 (excluding special items) $0.91 $0.52 $0.00 *Data on this slide is all based on con
Slide 4: Business Segment Results: Engineered Materials
Business Segment Results Engineered Materials $M USD Q3’12 Q3’11 %Δ Sales 224.1 199.3 12% Operating Earnings 40.5 30.0 35% Q3 Sales Comparison • Double-digit revenue growth driven by higher selling volumes across all Sales Growth 12% commercial aerospace end markets and rotorcraft Volume 9% • Levera
Slide 5: Business Segment Results: Umeco
Business Segment Results Umeco – As Adjusted $M USD Q3’12 Q3’11 %Δ Sales 66.8 N/A N/A Operating Earnings 2.9 N/A N/A Q3 Sales Comparison • Sales below expectations due to softer Sales Growth N/A demand in structural materials Volume N/A • Operating earnings includes about $1M of corporate allocation
Slide 6: Business Segment Results: In Process Separation
Business Segment Results In Process Separation $M USD Q3’12 Q3’11 %Δ Sales 98.1 89.7 9% Operating Earnings 24.4 17.3 41% • Strong selling volumes for mining Q3 Sales Comparison chemicals, notably in Eastern Europe and Africa Sales Growth 9% • Strong selling volumes for phosphine Volume 4% chemicals
Slide 7: Business Segment Results: Additive Technologies
Business Segment Results Additive Technologies $M USD Q3’12 Q3’11 %Δ Sales 66.4 74.4 -11% Operating Earnings 9.6 12.8 -25% Q3 Sales Comparison • Lower selling volumes for specialty additives due to soft demand, particularly in North Sales Growth -11% America and Europe Volume -9% • Maintaining earni
Slide 8: Special Items
Special Items Third Quarter 2012 • Continuing Operations (all in corporate and unallocated except inventory step-up): – Administrative and General, and Manufacturing Cost of Sales includes pre-tax net restructuring charges of $4.5M related to reductions in the stranded costs of acquired Umeco busine
Slide 9: Financial Results
Financial Results Third Quarter 2012 • As-Adjusted Continuing Comments (ex special items): – Overall sales up by 25% primarily due to Umeco acquisition. – Gross profit dollars up 30% to $139.9M and margin of 30.7% was higher by approximately 1 percentage point versus Q3’11 – Gross margin increase su
Slide 10: Discontinued Operations
Discontinued Operations Coating Resins (on the basis before being classified as discontinued operations) $M USD Q3’12 Q3’11 %Δ Sales 364.3 415.0 -12% Operating Earnings 24.3 19.7 23% Discontinued Basis Operating Earnings 40.0 35.0 20% Q3 Sales Comparison • Lower selling volumes across most product l
Slide 11: Cash Flow
Cash Flow Excludes Coating Resins and Umeco Working Capital Days 110 100 94 87 88 90 80 70 60 49 49 50 47 40 45 45 45 30 20 10 0 Q1 12 avg Q2 12 avg Q3 12 avg Inventory-DOS Acct Payable-DPO Acct Receivable-DSO 11
Slide 12: Balance Sheet
Balance Sheet Maintaining Liquidity • CAPEX of $49M in Q3 ’12; Estimate full year 2012 CAPEX of $200M • Share repurchase authorization now expanded to $650M • Balance on $170M draw down from credit facility is reduced to $25M • Investment grade ratings reaffirmed by Moody’s and Standard and Poor’s 1
Slide 13: 2012 Outlook – Continuing Operations
2012 Outlook – Continuing Operations Outlook table in Millions (except per share amount) Business Segment Net Sales Operating Earnings Guidance Engineered Materials $895 to $905 $163 to $168 In Process Separation $385 to $395 $92 to $96 Additive Technologies $270 to $280 $37 to $39 Umeco $155 to $16
Slide 14: NYSE: CYT
CYTEC Delivering Technology Beyond Our Customers’ Imagination™ NYSE: CYT
Slide 15: Appendix: Reconciliation of Non-GAAP Measures to GAAP Measures
Appendix Reconciliation of “Non‐GAAP” Measures to GAAP Measures Management believes that net after‐tax earnings and diluted earnings per share before special items, and gross margins adjusted for special items, which are non‐GAAP measures, are meaningful to investors because they provide a view of t
Slide 16: Appendix: Operating Earnings Analysis by Quarter
Appendix Operating Earnings Analysis by Quarter (unaudited) First Quarter 2011 Second Quarter 2011 Previously Less: CR Corporate Restated for Previously Less: CR Corporate Restated for Reported Results Allocation Disc Ops Reported Results Allocation Disc Ops Engineered Materials $ 25.1 $ 25.1 $ 28.1